Clinically meaningful response in difficult to treat type of CTCL PRINCETON, N.J., Feb. 11, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that Dr. Brian Poligone, clinical investigator and… Read More..

Specific therapeutic use claims in oral mucositis adds to existing composition of matter claims PRINCETON, N.J., Feb. 3, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today… Read More..

Following six consecutive months of revenue growth for the YouNow app since the integration of Props tokens, additional apps are adopting the token. Social chat app Camfrog is anticipated to introduce Props to its millions of community members on February 12, and P2P marketplace Listia announces today that it is… Read More..